Scientific Sessions 2024  /  Novel Mitral and Tricuspid Valve Therapies: Current Status and A Glimpse into the Future  /  Expansion of Indications for M-TEER: Evaluation of Transcatheter Repair in Lower Surgical Risk Cohorts (e.g. REPAIR-MR and PRIMARY)
Logo

American Heart Association

  184
  0

Final ID:

Expansion of Indications for M-TEER: Evaluation of Transcatheter Repair in Lower Surgical Risk Cohorts (e.g. REPAIR-MR and PRIMARY)

  • Hahn, Rebecca  ( COLUMBIA UNIVERSITY , New York , New York , United States )
    • Author Disclosures:
    Rebecca Hahn: DO have relevant financial relationships ; Speaker:Boston Scientific:Active (exists now) ; Speaker:Philips Healthcare:Active (exists now) ; Speaker:Edwards Lifescience:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Novel Mitral and Tricuspid Valve Therapies: Current Status and A Glimpse into the Future

Sunday, 11/17/2024 , 03:30PM - 04:30PM

Hall

More abstracts on this topic:
Outcomes Data for TEER in Mitral and Tricuspid Disease

Sorajja Paul, Fam Neil

Panel Discussion

Kodali Susheel, Kar Saibal, Salehi Negar

More abstracts from these authors:
Future Landscape of Mitral and Tricuspid Therapies (Including TMVR and TTVR and Other Strategies)

Hahn Rebecca

Panel Discussion

Hahn Rebecca

You have to be authorized to contact abstract author. Please, Login
Not Available